Search research articles
Contact Us
Filters
Showing results (281-290 of 408) with videos related to
Page
of 41
Sort By:
Endocrine Connections
|
January 24, 2019
Single-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
Alexander Tacey, Lewan Parker, Bu B Yeap, et al.
Cureus
|
October 3, 2025
Correction: Adolescents' Diabetes Self-Management Regimens and Outcomes During the COVID-19 Pandemic: A Scoping Review
Jason Nguyen, William Le, Roberta Brugger, et al.
Cureus
|
January 27, 2025
Adolescents' Diabetes Self-Management Regimens and Outcomes During the COVID-19 Pandemic: A Scoping Review
Jason Nguyen, William Le, Roberta Brugger, et al.
Current Problems in Diagnostic Radiology
|
April 2, 2026
Predicting radiology no-shows with machine learning: Methodological pitfalls and practical considerations
David Fussell, Justin Ling, Ziyue Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 19, 2019
Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia
Yi Huang, John Joseph, W Bastiaan de Boer, et al.
Clinical Chemistry and Laboratory Medicine
|
October 5, 2016
Harmonisation of serum dihydrotestosterone analysis: establishment of an external quality assurance program
Ronda F Greaves, Lisa Jolly, Michaela F Hartmann, et al.
Journal of Drugs in Dermatology : JDD
|
October 7, 2020
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 31, 2013
Long-term safety of abobotulinumtoxinA for the treatment of glabellar lines: results from a 36-month, multicenter, open-label extension study
Joel Schlessinger, Jeffrey S Dover, John Joseph, et al.
Journal of Drugs in Dermatology : JDD
|
October 12, 2021
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Journal of Tissue Engineering
|
April 15, 2021
Effective decellularisation of human saphenous veins for biocompatible arterial tissue engineering applications: Bench optimisation and feasibility in vivo testing
Nadiah S Sulaiman, Andrew R Bond, Vito D Bruno, et al.
Page
of 41
Search research articles
Search
Showing results (281-290 of 408) with videos related to
Sort By:
Page
of 41
Endocrine Connections
|
January 24, 2019
Single-dose prednisolone alters endocrine and haematologic responses and exercise performance in men
Alexander Tacey, Lewan Parker, Bu B Yeap, et al.
Cureus
|
October 3, 2025
Correction: Adolescents' Diabetes Self-Management Regimens and Outcomes During the COVID-19 Pandemic: A Scoping Review
Jason Nguyen, William Le, Roberta Brugger, et al.
Cureus
|
January 27, 2025
Adolescents' Diabetes Self-Management Regimens and Outcomes During the COVID-19 Pandemic: A Scoping Review
Jason Nguyen, William Le, Roberta Brugger, et al.
Current Problems in Diagnostic Radiology
|
April 2, 2026
Predicting radiology no-shows with machine learning: Methodological pitfalls and practical considerations
David Fussell, Justin Ling, Ziyue Wang, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
July 19, 2019
Long-term Liver-related Outcomes of Patients With Chronic Liver Diseases in Australia
Yi Huang, John Joseph, W Bastiaan de Boer, et al.
Clinical Chemistry and Laboratory Medicine
|
October 5, 2016
Harmonisation of serum dihydrotestosterone analysis: establishment of an external quality assurance program
Ronda F Greaves, Lisa Jolly, Michaela F Hartmann, et al.
Journal of Drugs in Dermatology : JDD
|
October 7, 2020
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]
|
December 31, 2013
Long-term safety of abobotulinumtoxinA for the treatment of glabellar lines: results from a 36-month, multicenter, open-label extension study
Joel Schlessinger, Jeffrey S Dover, John Joseph, et al.
Journal of Drugs in Dermatology : JDD
|
October 12, 2021
IncobotulinumtoxinA Demonstrates Safety and Prolonged Duration of Effect in a Dose-Ranging Study for Glabellar Lines
Martina Kerscher, Sabrina Fabi, Tanja Fischer, et al.
Journal of Tissue Engineering
|
April 15, 2021
Effective decellularisation of human saphenous veins for biocompatible arterial tissue engineering applications: Bench optimisation and feasibility in vivo testing
Nadiah S Sulaiman, Andrew R Bond, Vito D Bruno, et al.
Page
of 41